SCHEMBL576045

SCHEMBL576045

Cc1cccc(Sc2cccc(C)c2C)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.53
HTR3A P46098 4/20 0.53
CYP1A2 P05177 3/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2D6 P10635 2/20 0.53
CYP2C9 P11712 2/20 0.53
TRPA1 O75762 2/20 0.46
ATM Q13315 1/20 0.46
NOTUM Q6P988 1/20 0.42
CYP2A6 P11509 2/20 0.41
TSHR P16473 2/20 0.40
ACHE P22303 1/20 0.40
ALDH1A1 P00352 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29687933 1.00 HTR1A (0.53) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL29589002 1.00 HTR1A (0.53) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL29073066 0.95 HTR1A (0.54) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL9488937 0.93 HTR1A (0.53) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL9488037 0.87 HTR1A (0.45) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL16242606 0.85 CYP3A4 (0.47) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL9485979 0.85 HTR1A (0.44) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL31005148 0.84 L3MBTL1 (0.50) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL9488180 0.84 CYP1A2 (0.42) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL9487914 0.84 L3MBTL1 (0.50) HTR1AHTR3ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2481760-B1 INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION AND POLYMERIZATION METHOD USING SAME CHINA PETROLEUM & CHEM CORP (CN) 2021-05-05 EP claimed
WO-2015079018-A1 SYNTHESIS OF VORTIOXETINE VIA (2-(PIPERAZINE-1 -YL)PHENVL)LITHIUM INTERMEDIATES LEK PHARMACEUTICALS D.D. (SI) 2015-06-04 WO claimed
CN-102532368-B Rare earth catalyst and method for polymerizing conjugated diene by using same UNIV BEIJING CHEMICAL 2014-04-02 CN claimed
CN-102532368-A Rare earth catalyst and method for polymerizing conjugated diene by using same UNIV BEIJING CHEMICAL 2012-07-04 CN claimed
WO-2007005609-A2 SYNTHESIS OF LABELED COMPOUNDS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2007-01-11 WO claimed
CN-118923228-A Display device and photosensitive composition 东丽株式会社 2024-11-08 CN disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
EP-3848399-B1 TRANSITION METAL COMPOUND AND METHOD FOR PRODUCING OLEFIN POLYMER IDEMITSU KOSAN CO (JP) 2024-07-10 EP disclosed
CN-113402375-B Formation of alpha, beta-unsaturated carboxylic acids and salts thereof from metal lactones and anionic polyelectrolytes 切弗朗菲利浦化学公司 2024-04-02 CN disclosed
US-11795188-B2 Transition metal compound and method for producing olefin polymer IDEMITSU KOSAN CO., LTD. (JP) 2023-10-24 US disclosed
US-20230235202-A1 PLASTICIZER FOR RESINS IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-27 US disclosed
CN-116239460-A Continuous process for converting olefins and carbon dioxide to acrylic acid salts by means of a solution phase reactor 切弗朗菲利浦化学公司 2023-06-09 CN disclosed
EP-1247814-A1 TRANSITION METAL COMPOUNDS, POLYMERIZATION CATALYSTS FOR OLEFINS, OLEFIN POLYMERS AND PROCESS FOR THEIR PRODUCTION IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2002-10-09 EP disclosed
EP-1241206-A1 POLYPROPYLENE FILM AND MULTILAYERED LAMINATE IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2002-09-18 EP disclosed
EP-1231236-A1 POLYPROPYLENE FILM AND MULTILAYERED LAMINATE IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2002-08-14 EP disclosed
EP-1231226-A1 ROLLED POLYPROPYLENE AND INJECTION-MOLDED POLYPROPYLENE IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2002-08-14 EP disclosed
EP-1227112-A1 PROPYLENE POLYMERS AND RESIN COMPOSITION AND MOLDING CONTAINING THE POLYMERS IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2002-07-31 EP disclosed
US-5206383-A Melt processibility, tensile strength, heat resistance, toughness ALLIED-SIGNAL INC. (US) 1993-04-27 US disclosed
EP-0440106-A2 Process for preparing polyarylene thioethers SEISAN KAIHATSU KAGAKU KENKYUSHO (JP) 1991-08-07 EP disclosed
US-4837301-A FROM ALKALI MTEAL SULFIDES AND AROMATIC DIHALOGEN COMPOUNDS; IMPROVED CORROSION RESISTANCE BAYER AKTIENGESELLSCHAFT (DE) 1989-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795188-B2 Transition metal compound and method for producing olefin polymer H1-0, C9, C5 HTR1A 1603/4885HTR3A 3329/4885CYP1A2 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.